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Summary 
Conventional radiotherapy with X- and γ-rays is one of the 
common and effective treatments of cancer. High energy 
hadrons, i.e., charged particles like protons and 12C ions, due to 
their specific physics and radiobiological advantages are 
increasingly used. In this study, effectiveness of different 
radiation types is evaluated on the radio-resistant human HTB140 
melanoma cells. The cells were irradiated with γ-rays, the 62 MeV 
protons at the Bragg peak and in the middle of the spread-out 
Bragg peak (SOBP), as well as with the 62 MeV/u 12C ions. The 
doses ranged from 2 to 24 Gy. Cell survival and proliferation 
were assessed 7 days after irradiation, whereas apoptosis was 
evaluated after 48 h. The acquired results confirmed the high 
radio-resistance of cells, showing better effectiveness of protons 
than γ-rays. The best efficiency was obtained with 12C ions due to 
higher linear energy transfer. All analyzed radiation qualities 
reduced cell proliferation. The highest proliferation was detected 
for 12C ions because of their large killing capacity followed by 
small induction of reparable lesions. This enabled unharmed cells 
to preserve proliferative activity. Irradiations with protons and 12C 
ions revealed similar moderate pro-apoptotic ability that is in 
agreement with the level of cellular radio-resistance. 
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Introduction 
The secret of modern radiotherapy is to place the 
beam on the target with the desired dose, while sparing 
surrounding normal tissue. In the context of improving 
radiotherapy transition from conventional, i.e., photon 
radiation such as X- and γ-rays, to hadronic beams like 
protons and heavier ions is under way (Blattmann 1994, 
Amaldi and Kraft 2005).  
Particles like protons and heavier ions have 
advantages for therapy compared to conventional 
radiation, such as well defined range, small lateral 
scattering and high energy deposition just before the end 
of the range, defined as the Bragg peak. The Bragg peak 
results from the increased ionization density or linear 
energy transfer (LET), leading to the rise of biological 
effectiveness toward the end of the particle range. Protons 
and heavier ions are considered as high LET radiation, 
although heavier ions have rather higher LET values. 
Therefore, the effect on DNA of heavier ions with respect 
to protons can be compared as the effect of “cannon ball” 
to “bullet” (Gerweck and Kozin 1999).  
The commonly used parameter for assessment of 
radiation efficiency is the relative biological effectiveness 
(RBE), which reflects biological effectiveness of the 
specific type of ionizing radiation in comparison to the 
reference radiation, i.e., X- or γ-rays. The RBE increases 
with LET to reach its maximum value in the range from ~ 
30 to 200 keV/μm (Barendsen 2000, Belli et al. 2000). It 
depends on the relative dose, ion species, initial energy of 
the beam, tissue and the analyzed biological end-point 
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(Kempe et al. 2007). 
Since the Bragg peak is very narrow, in order to 
encompass the treatment volume it has to be spread-out 
by modulating the particle energy. For the improvement 
of radiotherapy, investigations of the effects obtained 
within the spread-out Bragg peak (SOBP) are of 
particular importance (Egger et al. 2003). Carbon (12C) 
ions have some advantages, as compared to γ-rays, but 
also relative to protons. The main advantage of carbon 
beams with respect to protons is a favorable depth profile 
of the RBE. The RBE values for 12C ions, due to higher 
LET attain larger values than for protons (Amaldi and 
Kraft 2005). Clinical results have shown that 12C ion 
therapy can provide a sufficient dose to the tumor volume 
with a rather low destruction of the surrounding normal 
tissues (Tsujii et al. 2007).  
The spectrum of induced lesions such as base 
damage, sugar damage, single strand breaks (SSB), 
double strand breaks (DSB), DNA-DNA and DNA-
protein cross links, as well as their spatial distribution 
depends on radiation quality (Schwartz et al. 1991, Belli 
et al. 2002). Low LET radiation usually induces reparable 
single damages in DNA chain, while high LET radiation 
provokes multiple irreparable DNA breaks (Mulford et 
al. 2005).  
Experimental results presented in this study are a 
part of an ongoing long-term research program 
accomplished within international collaboration of the 
Vinča Institute of Nuclear Sciences, Belgrade, Serbia and 
Istituto Nazionale di Fisica Nucleare, Laboratori 
Nazionali del Sud, Catania, Italy. These results represent 
chosen segments of an extensive investigation of 
radiobiological parameters and viability levels of a 
resistant human HTB140 melanoma cell line after 
exposure to conventional and different high ionizing 
radiation. To analyse and predict success of potential 
therapeutic irradiations for the radio-resistant limit case, 
assessment of the effects of two types of proton beams (at 
the Bragg peak maximum and along SOBP) and of a 12C 
ion beam was performed. 
  
Methods 
 
Cell culture 
Human melanoma HTB140 cell line was 
obtained from the American Tissue Culture Collection 
(ATCC, Manassas, VA, USA). The cells were grown in 
the RPMI 1640 medium supplemented with 10 % FCS 
(Sigma Chemical Co., Steinheim, Germany) and 
penicillin/streptomycin (Sigma), in a humidified 
atmosphere of 5 % CO2 at 37 °C (Heraeus, Hanau, 
Germany). 
 
Irradiation conditions 
Irradiations with protons and 12C ions were 
carried out at the Istituto Nazionale di Fisica Nucleare, 
Laboratori Nazionali del Sud (INFN - LNS), Italy. 
Reference dosimetry was performed by the plane-parallel 
PTW 34045 Markus ionization chamber (Advanced 
Markus Chamber, 0.02 cm2, Type 34045, PTW Freiberg, 
Germany), calibrated according to the International 
Atomic Energy Agency (IAEA) code of practice (IAEA-
TRS-398 2000, Cirrone et al. 2004). All cell irradiations 
were carried out in air at room temperature. 
For analysis of the effects of proton irradiations 
on the HTB140 melanoma cells, two experimental set-
ups were applied. In the first case irradiations were 
performed with the monoenergetic 62 MeV proton beam. 
Irradiation position at the Bragg peak was simulated by 
inserting a 25 mm thick Perspex plate (Polymethyl 
methacrylate - PMMA) between the final collimator and 
the cell monolayer. Single doses delivered to the cells 
ranged from 8 to 24 Gy. The relative dose was 90.4±4 %, 
with the corresponding LET value of 9.08±0.38 keV/μm. 
In the second experimental set-up, the HTB140 
melanoma cells were irradiated with the therapeutic 62 
MeV proton beam. The irradiation position in the middle 
of the SOBP was obtained by interposing 16.3 mm thick 
Perspex plate between the final collimator and the cell 
monolayer. Single doses delivered to the cells were 
ranged from 2 to 16 Gy. The relative dose was 
99.42±0.58 %, with the corresponding LET value of 
4.71±0.15 keV/μm. The LET values were obtained by 
numerical simulations carried out with the GEANT4 code 
(GEANT4 1998). In both experiments with protons the 
average dose rate was 15 Gy/min. 
For the analysis of effects of 12C ions cells were 
irradiated with 62 MeV/u 12C ions produced by the 
superconducting cyclotron in INFN – LNS, Catania. The 
position within the Bragg peak was obtained by 
interposing Perspex plate of 8.8 mm, giving the relative 
dose of 92.11±4.76 %. Single doses delivered to the cells 
ranged from 2 to 16 Gy at the dose rate of 11.03±0.27 
Gy/min. The corresponding LET value was 415.27±42.84 
keV/μm. 
Irradiations with γ-rays, at the same dose levels, 
were performed using 60Co source at the Vinča Institute 
of Nuclear Sciences in Belgrade, Serbia. Applied doses 
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ranged from 8 to 24 Gy, at the average dose rate of 
1 Gy/min.  
 
Clonogenic Assay 
For the colony assay cells were harvested by 
trypsinization and seeded into 25 cm2 flasks at a suitable 
number. After the incubation at 37 °C for 7 days colonies 
were fixed with methanol, stained with 10 % Giemsa 
solution and counted. Groups of more than 50 cells were 
scored as colonies. Survival was calculated by comparing 
the number of colonies in irradiated samples with 
untreated controls.  
 
Proliferation assay 
The 5-bromo-2-deoxyuridine (BrdU) assay 
(Roche Diagnostics GmbH, Mannheim, Germany) was 
used to measure cell proliferation. Assay was performed 
according to the manufacturer’s instructions. The 
HTB140 melanoma cells were incubated with BrdU 
labeling solution for 2 h, fixed and anti-BrdU-POD 
antibody was added. After removing antibody conjugate, 
substrate solution was added and incubated until the color 
development was sufficient for the photometric detection 
(5-30 min). The reaction was stopped by adding 1 M 
H2SO4 solution. The absorbance was measured using a 
microplate reader (Wallac, VICTOR2 1420 Multilabel 
counter, PerkinElmer, Turku, Finland) at a test 
wavelength of 450 nm and a reference wavelength of 
690 nm.   
 
Flow cytometric analysis  
Apoptotic cells were quantified by Annexin-V-
FLUOS Staining kit (Roche Diagnostics GmbH, 
Mannheim, Germany). The assay was performed according 
to manufacturer's instructions. Cells were trypsinized, 
washed in ice-cold PBS and resuspended in 100 µl 
Annexin-V-FLUOS labeling solution (containing Annexin-
V-FLUOS labeling reagent and propidium iodide - PI). 
After incubation for 15 to 30 min in the dark, 500 µl of 
incubation buffer was added per sample. In each sample, 
10 000 cells were analyzed on the FACSCalibur (Becton 
Dickinson, USA). The number of apoptotic cells was 
calculated using the Cell Quest software.  
 
Statistical analysis  
Triplicate measurements were made during each 
experiment, while each experiment has been repeated 
three times, except for the cell proliferation assay that 
was performed in the quadruplicate experiments. The 
significance of differences between control and treated 
cells was assessed by the independent Student’s t-test, 
with the level of significance set at p<0.05. Results were 
presented as the mean ± S.D. (standard deviation).  
 
Results 
 
Cellular responses to different types of radiation 
were analyzed on the radio-resistant human HTB140 
melanoma cell line. Clonal survival as the most important 
parameter that describes the level of cellular radio-
sensitivity was analyzed 7 days after irradiation, a time 
that is necessary for the development of the radio-
biological response of this cell line. Experimental data 
were fitted to the linear-quadratic equation: S = exp (– α 
D – β D2), where S is the surviving fraction for the dose 
D, while α and β are the fitting parameters. Data obtained 
by the clonogenic assay and the fitted curves are shown 
in Figure 1. 
 
 
 
 
Fig. 1. Dose dependent surviving fractions of HTB140 cells 
irradiated with γ-rays, protons at the Bragg peak, protons in the 
middle of the SOBP and 12C ions. 
 
 
Considering very high radio-resistance and to 
overcome a moderate response the HTB140 cells were 
irradiated with γ-rays and protons at the Bragg peak using 
also the doses that are higher than those used in therapy, 
i.e. 8, 12, 16, 20 and 24 Gy. Although the applied doses 
were so high, the response remained moderate. For the 
irradiations with the protons in the middle of the 
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therapeutic SOBP and with 12C ions the doses employed 
where those belonging to the therapeutic range, i.e. 2, 4, 
8, 12 and 16 Gy. The levels of cell inactivation produced 
by both types of proton irradiation, as well as by carbon 
ions are stronger than that of γ-rays in the whole dose 
range. Also, 12C ions have shown better killing ability 
than protons in the dose range from 2 to 16 Gy. 
 
 
 
 
Fig. 2. RBE as a function of LET for protons at the Bragg peak, 
protons in the middle of the SOBP and 12C ions. 
 
 
The efficiency of protons and 12C ions to 
inactivate cells with respect to conventional radiation  
(γ-rays) was analyzed through relative biological 
effectiveness at 2 Gy, RBE (2 Gy, γ), representing the 
dose ratio for the isoeffect. Analyzed types of radiation 
have shown different RBE for applied LET values and 
are given in Figure 2. The RBE values for protons, proton 
mid SOBP and 12C ions were 1.69±0.17, 2.09±0.36 and 
2.9±0.21, respectively.  
Another important biological end-point for the 
analysis of the level of cellular radio-sensitivity is the cell 
proliferation. To compare the three types of radiation the 
chosen doses for this assay were 8, 12 and 16 Gy. Figure 
3 shows that the proliferation capacity of the HTB140 
melanoma cells after γ-irradiation was from 34 to 40 %, 
when compared to the control value. Similar results were 
obtained after the irradiation with protons close to the 
Bragg peak. When irradiation position was in the middle 
of the proton SOBP, the proliferation of melanoma cells 
was higher than in the two previous cases, ranging from 
43 to 46 %. The highest level of cell proliferation was 
attained after irradiations with 12C ions and was from  
75 to 87 %, as compared to non-irradiated control. 
The percentage of apoptosis was evaluated 48 h 
after irradiation. For the analysis of apoptosis, the applied 
doses were 8, 12 and 16 Gy. In previous studies, it was 
shown that γ-rays did not induce apoptosis in the 
HTB140 melanoma cells (Petrović et al. 2006). After 
proton irradiation close to the Bragg peak the level of 
apoptosis was ~ 18 %, in the whole dose range. 
Irradiations with 12C ions did not additionally affect 
apoptosis. The level of apoptotic cells was around ~ 15 % 
for all three doses applied. 
 
Discussion 
 
Investigation of the effects of different radiation 
types, particularly regarding their LET values and track 
structure, were undertaken on the HTB140 human 
melanoma cells, representing the limit case of radio-
resistance (Petrović et al. 2006, Ristić-Fira et al. 2007). 
The aim of this study is to reveal how far it is possible to 
go in inactivation, also considered as cell killing, of this 
cell line using radiation species with progressive 
efficiency. Moreover, the obtained results would serve for 
the characterization of the therapeutic beam at INFN – 
LNS, as well as for the provision of reliable experimental 
data for the validation and further development of the 
treatment planning system. Cellular responses to two 
different types of protons and carbon ions are evaluated 
through biological endpoints that were cell survival, 
proliferation and induction of apoptosis.  
Due to the increased dose levels, the fitted 
curves for γ-rays and protons at the Bragg peak shown in 
Figure 1 display the well known shoulder shape (Bettega 
et al. 2000, Petrovic et al. 2006), although the curvatures 
are modest with a weak inclination. However, the 
stronger curvature and inclination of the proton curve 
illustrates their better killing ability. The fitted curves for 
the protons in the middle of the therapeutic SOBP and for 
12C ions are straight lines, because the lower doses 
applied produced data that allowed fitting only to the 
linear component of the linear-quadratic equation. Still, 
these two straight lines have larger slopes than the other 
two curves. The one for 12C ions revealed the highest 
level of cell inactivation. Literature data suggested that 
12C ions with LET values of 20, 40 and 80 keV/μM 
showed better effectiveness on glioblastoma cells and 
fibroblasts (Tsuboi et al. 2007). 
The RBE that are presented in Figure 2 pointed 
out that the highest value is obtained for the highest LET 
that is produced by 12C ions. As for the two proton types 
of irradiation, higher RBE value with lower LET is 
attained with protons at the mid of the SOBP as 
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compared to the protons at the Bragg peak. Although this 
may seem contradictory, the explanation is as follows. In 
the case of 12C ions and protons at the Bragg peak the 
beams are practically monoenergetic, meaning that the 
higher LET the greater cell inactivation is obtained, i.e. 
RBE. The beam of protons at the mid of the SOBP, due 
to its spreading is not monoenergetic and is characterized 
by a wide spectrum of proton energies. Therefore, its 
LET represents the mean value obtained from the series 
of high and low LET with obviously very different killing 
potential that is not linear. The contributions of the high 
LET components to the mean LET value and to the RBE 
are not the same. High LET components in the middle of 
the SOBP contribute considerably more to the 
inactivation of cells. This gives higher RBE for lower 
mean LET than in the case of the monoenergetic proton 
beam with the single although higher LET value. 
Cell proliferation was evaluated after exposure 
of cells to irradiations with the therapeutic doses, i.e. 8, 
12 and 16 Gy. Obtained results are shown in Figure 3. 
Irradiations with γ-rays and protons at the Bragg peak 
significantly reduced the HTB140 cell proliferation with 
a large and similar number of cells being arrested in order 
to repair radiation damage or being killed due to 
irreparable lesions. According to Figure 1 a greater 
portion of cells are killed after irradiation with protons at 
the Bragg peak. Similar results for antiproliferative 
effects of protons were reported for lung epithelial cells 
(Baluchamy et al. 2010). After irradiation in the mid of 
the SOBP again significantly low cell proliferation is 
obtained. Still, it is somewhat higher with respect to  
γ-rays and protons at the Bragg peak. This is caused by 
the contributions of higher LET components that increase 
cell killing, as given in Figure 1, and reduce cell arrest. 
Carbon ions, due to their even higher LET and greater 
killing, reveal high cell proliferation because more 
irreparable, but much less reparable lesions are induced. 
Previous studies revealed that γ-rays did not 
induce apoptotic cell death in the HTB140 cells (Petrović 
et al. 2006). Similar results were reported in two different 
glioblastoma cell lines that were resistant to the induction 
of apoptosis with γ-rays (Tsuboi et al. 2007).  The level 
of apoptosis after proton irradiation is in the range 
already shown for other resistant cell lines (Kumala et al. 
2003).  For protons and 12C ions, 48 h after irradiations, 
the percentage of apoptotic cells ranges from 13 to 18 %. 
A non-linear dependence of apoptosis on dose (8 to 
16 Gy) is in agreement with the non-linear killing 
capacity in the same dose range (Fig. 1) that was already 
noticed (Petrović et al. 2010). Similar pro-apoptotic level 
for protons and 12C ions were reported for human glioma, 
PC3 prostate adenocarcinoma, Ca301D thyreoid 
carcinoma and MCF7 mammary adenocarcinoma cells 
(Di Pietro et al. 2006, Jinno-Oue et al. 2010).  
Obtained results point out that protons and 12C 
ions have better antitumor activity on resistant melanoma 
cells than conventional radiation. The best effectiveness 
in elimination of very resistant melanoma cells was 
achieved by 12C ions due to their higher LET. 
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